Filing Details

Accession Number:
0001127602-12-003916
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-03 14:51:42
Reporting Period:
2012-02-01
Filing Date:
2012-02-03
Accepted Time:
2012-02-03 14:51:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265751 Nancy Leaming Biogen Idec Inc.
133 Boston Post Road
Weston MA 02493
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-01 5,700 $59.17 12,035 No 4 M Direct
Common Stock Disposition 2012-02-01 5,700 $120.00 6,335 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-02-01 5,700 $0.00 5,700 $59.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-06-19 2018-06-18 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities and Exchange Act of 1934.